Cargando…
6 Circulating miRNAs can be used as Non-invasive Biomarkers for the Detection of Cervical Lesions
Background: Cervical cancer is the most common malignant tumor in the female reproductive system, while the efficacy of routine screening strategy is unsatisfied. New molecular tests need to be developed. miRNAs participate in many pathologic processes, and circulating miRNAs are promising non-invas...
Autores principales: | Ning, Ruoqi, Meng, Silu, Wang, Lin, Jia, Yao, Tang, Fangxu, Sun, Haiying, Zhang, Zhi, Zhang, Chong, Fan, Xinran, Xiao, Bing, Yang, Chunhua, Li, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317520/ https://www.ncbi.nlm.nih.gov/pubmed/34335927 http://dx.doi.org/10.7150/jca.51141 |
Ejemplares similares
-
A case of SLE with COVID-19 and multiple infections
por: Ning, Ruoqi, et al.
Publicado: (2020) -
Comparison of clinical and microbiological diagnoses for older adults with COVID-19 in Wuhan: a retrospective study
por: Sun, Haiying, et al.
Publicado: (2020) -
Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery
por: Sun, Haiying, et al.
Publicado: (2018) -
Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker
por: Zhang, Jianwei, et al.
Publicado: (2022) -
Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer
por: Shi, Can, et al.
Publicado: (2019)